Literature DB >> 28550087

Transcriptional networks in rodent models support a role for gut-brain communication in neurogenic hypertension: a review of the evidence.

Jasenka Zubcevic1,2, Ashley Baker1,3, Christopher J Martyniuk4,3,2.   

Abstract

Hypertension (HTN) is the most prevalent condition observed in primary health care. Hypertension shows complex etiology, and neuroinflammation, overactive sympathetic drive, and the microbiome are each associated with the disease. To obtain mechanistic perspective into neurogenic HTN, we first constructed a framework for transcriptional regulators of the disease using the Comparative Toxicogenomics Database. This approach yielded a core group of 178 transcripts that are prevalent in studies of HTN, including leptin and neuropeptide Y. We then conducted a meta-analysis for transcriptome data generated in brain tissue from HTN studies. Eight expression studies were reanalyzed, in which transcriptomics was conducted in hypertensive animal models [spontaneously hypertensive rats (SHR) and high blood pressure (BPH/2J) Schlager mice] (140 microarrays). Most strikingly, a gut-brain connection was a dominant theme in both rodent models of HTN. The transcriptomic data in the rat CNS converged on processes that included gastrointestinal motility and appetite, among others. In the mouse model, pathways converged on gastrointestinal transit. Thus, our data provide a powerful review of current molecular evidence of the interplay between gut and brain in HTN. Analyses of meta-genome data also suggested that transcriptome networks related to natriuresis, thermoregulation, reproduction (lactation and pregnancy), and vasoconstriction were associated to HTN, supporting physiological observations in independent studies by others. Lastly, we present novel transcriptome networks that may contribute to a neurogenic origin of HTN. Using this framework, new therapeutic targets can be proposed and investigated in treatment strategies.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  cardiovascular disease; meta-analysis; neurogenic hypertension; subnetwork enrichment; transcriptomics

Mesh:

Year:  2017        PMID: 28550087     DOI: 10.1152/physiolgenomics.00010.2017

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  6 in total

1.  Genetic ablation of bone marrow beta-adrenergic receptors in mice modulates miRNA-transcriptome networks of neuroinflammation in the paraventricular nucleus.

Authors:  Christopher J Martyniuk; Ruben Martínez; Daniel J Kostyniuk; Jan A Mennigen; Jasenka Zubcevic
Journal:  Physiol Genomics       Date:  2020-02-24       Impact factor: 3.107

Review 2.  Tumor Necrosis Factor Alpha and the Gastrointestinal Epithelium: Implications for the Gut-Brain Axis and Hypertension.

Authors:  Christopher L Souders; Jasenka Zubcevic; Christopher J Martyniuk
Journal:  Cell Mol Neurobiol       Date:  2021-02-16       Impact factor: 5.046

Review 3.  Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice.

Authors:  Kristy L Jackson; Geoffrey A Head; Cindy Gueguen; Emily R Stevenson; Kyungjoon Lim; Francine Z Marques
Journal:  Front Physiol       Date:  2019-10-18       Impact factor: 4.566

Review 4.  The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health.

Authors:  Ana Nogal; Ana M Valdes; Cristina Menni
Journal:  Gut Microbes       Date:  2021 Jan-Dec

5.  Butyrate regulates inflammatory cytokine expression without affecting oxidative respiration in primary astrocytes from spontaneously hypertensive rats.

Authors:  Tao Yang; Vermali Rodriguez; Wendi L Malphurs; Jordan T Schmidt; Niousha Ahmari; Colin Sumners; Christopher J Martyniuk; Jasenka Zubcevic
Journal:  Physiol Rep       Date:  2018-07

6.  Revisiting Inbred Mouse Models to Study the Developing Brain: The Potential Role of Intestinal Microbiota.

Authors:  Reinaldo B Oriá; João O Malva; Patricia L Foley; Raul S Freitas; David T Bolick; Richard L Guerrant
Journal:  Front Hum Neurosci       Date:  2018-09-19       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.